Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 42

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Coffee Intake Is Associated with a Lower Liver Stiffness in Patients with Non-Alcoholic Fatty Liver Disease, Hepatitis C, and Hepatitis B

Hodge, Alexander, Lim, Sarah, Goh, Evan, Wong, Ophelia, Marsh, Philip, Knight, Virginia, Sievert, William, De Courten, Barbora·2017·Nutrients
DOI 10.3390/nu9010056
Open this paper in CoChat — free account

Abstract

There is emerging evidence for the positive effects or benefits of coffee in patients with liver disease. We conducted a retrospective cross-sectional study on patients with non-alcoholic fatty liver disease (NAFLD), hepatitis C virus (HCV), and hepatitis B virus (HBV) infection to determine the effects of coffee intake on a non-invasive marker of liver fibrosis: liver stiffness assessed by transient elastography (TE). We assessed coffee and tea intake and measured TE in 1018 patients with NAFLD, HCV, and HBV (155 with NAFLD, 378 with HCV and 485 with HBV). Univariate and multivariate regression models were performed taking into account potential confounders. Liver stiffness was higher in males compared to females (p < 0.05). Patients with HBV had lower liver stiffness than those with HCV and NAFLD. After adjustment for age, gender, smoking, alcohol consumption, M or XL probe, and disease state (NAFLD, HCV, and HBV status), those who drank 2 or more cups of coffee per day had a lower liver stiffness (p = 0.044). Tea consumption had no effect (p = 0.9). Coffee consumption decreases liver stiffness, which may indicate less fibrosis and inflammation, independent of disease state. This study adds further evidence to the notion of coffee maybe beneficial in patients with liver disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu9010056

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 49

  1. Ponte, 2002, The ‘Latte Revolution’? Regulation, markets and consumption in the global coffee chain, World Dev., 30, 1099, 10.1016/S0305-750X(02)00032-3 · DOI
  2. Spiller, 1984, The chemical components of coffee, Prog. Clin. Biol. Res., 158, 91
  3. Butt, 2011, Coffee and its consumption: Benefits and risks, Crit. Rev. Food Sci. Nutr., 51, 363, 10.1080/10408390903586412 · DOI · Paper page
  4. Chrysant, 2015, Coffee consumption and cardiovascular health, Am. J. Cardiol., 116, 818, 10.1016/j.amjcard.2015.05.057 · DOI
  5. Marventano, 2016, Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies, Clin. Nutr., 35, 1269, 10.1016/j.clnu.2016.03.012 · DOI
  6. Adeney, 2007, Coffee consumption and the risk of gestational diabetes mellitus, Acta Obstet. Gynecol. Scand., 86, 161, 10.1080/00016340600994992 · DOI
  7. Knekt, 2008, Prospective study of coffee consumption and risk of Parkinson's disease, Eur. J. Clin. Nutr., 62, 908, 10.1038/sj.ejcn.1602788 · DOI · Paper page
  8. Carman, 2014, Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer’s disease, J. Nutr. Health Aging, 18, 383, 10.1007/s12603-014-0021-7 · DOI
  9. Zhao, 2015, Association of coffee drinking with all-cause mortality: A systematic review and meta-analysis, Public Health Nutr., 18, 1282, 10.1017/S1368980014001438 · DOI
  10. Morisco, 2014, Coffee and liver health, J. Clin. Gastroenterol., 48, S87, 10.1097/MCG.0000000000000240 · DOI
  11. Casiglia, 1993, Unexpected effects of coffee consumption on liver enzymes, Eur. J. Epidemiol., 9, 293, 10.1007/BF00146266 · DOI
  12. Ruhl, 2005, Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States, Gastroenterology, 128, 24, 10.1053/j.gastro.2004.09.075 · DOI · Paper page
  13. Cadranel, 2002, Good clinical practice guidelines for fine needle aspiration biopsy of the liver: Past, present and future, Gastroenterol. Clin. Biol., 26, 823
  14. Foucher, 2006, Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study, Gut, 55, 403, 10.1136/gut.2005.069153 · DOI · Paper page
  15. Berzigotti, 2014, Getting closer to a point-of-care diagnostic assessment in patients with chronic liver disease: Controlled attenuation parameter for steatosis, J. Hepatol., 60, 910, 10.1016/j.jhep.2014.01.017 · DOI
  16. Ribeiro, 2009, Fatty liver characterization and classification by ultrasound, Pattern Recognit. Image Anal., 5524, 354, 10.1007/978-3-642-02172-5_46 · DOI
  17. Yoneda, 2007, Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD), Gut, 56, 1330, 10.1136/gut.2007.126417 · DOI
  18. Castera, 2012, Noninvasive methods to assess liver disease in patients with hepatitis B or C, Gastroenterology, 142, 1293.e4, 10.1053/j.gastro.2012.02.017 · DOI · Paper page
  19. Shi, 2014, Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: A meta-analysis of diagnostic accuracy, J. Gastroenterol. Hepatol., 29, 1149, 10.1111/jgh.12519 · DOI
  20. Khalaf, 2015, Coffee and caffeine are associated with decreased risk of advanced hepatic fibrosis among patients with hepatitis C, Clin. Gastroenterol. Hepatol., 13, 1521.e3, 10.1016/j.cgh.2015.01.030 · DOI
  21. Salomone, 2015, Coffee consumption and nonalcoholic fatty liver onset: A prospective study in the general population, Transl. Res., 165, 428, 10.1016/j.trsl.2014.10.008 · DOI
  22. Freedman, 2009, Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C, Hepatology, 50, 1360, 10.1002/hep.23162 · DOI · Paper page
  23. Freedman, 2011, Coffee consumption is associated with response to peginterferon and ribavirin therapy in patients with chronic hepatitis C, Gastroenterology, 140, 1961, 10.1053/j.gastro.2011.02.061 · DOI
  24. Tanida, 2015, Inhibitory effects of caffeic acid, a coffee-related organic acid, on the propagation of hepatitis C virus, Jpn. J. Infect. Dis., 68, 268, 10.7883/yoken.JJID.2014.309 · DOI
  25. Cardin, 2013, Effects of coffee consumption in chronic hepatitis C: A randomized controlled trial, Dig. Liver Dis., 45, 499, 10.1016/j.dld.2012.10.021 · DOI
  26. Catalano, 2010, Protective role of coffee in non-alcoholic fatty liver disease (NAFLD), Dig. Dis. Sci., 55, 3200, 10.1007/s10620-010-1143-3 · DOI
  27. Uribe, 2012, High coffee intake is associated with lower grade nonalcoholic fatty liver disease: The role of peripheral antioxidant activity, Ann. Hepatol., 11, 350, 10.1016/S1665-2681(19)30931-7 · DOI
  28. Molloy, 2012, Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis, Hepatology, 55, 429, 10.1002/hep.24731 · DOI
  29. Bambha, 2014, Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis, Liver Int., 34, 1250, 10.1111/liv.12379 · DOI
  30. Graeter, T., Niedermayer, P.C., Mason, R.A., Oeztuerk, S., Haenle, M.M., Koenig, W., Boehm, B.O., and Kratzer, W. (2015). Coffee consumption and NAFLD: A community based study on 1223 subjects. BMC Res. Notes, 8. · DOI
  31. Sasso, 2010, Controlled attenuation parameter (CAP): A novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes, Ultrasound Med. Biol., 36, 1825, 10.1016/j.ultrasmedbio.2010.07.005 · DOI
  32. Wang, 2015, Controlled attenuation parameter for assessment of hepatic steatosis grades: A diagnostic meta-analysis, Int. J. Clin. Exp. Med., 8, 17654
  33. Kumar, 2013, Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: Does etiology affect performance?, J. Gastroenterol. Hepatol., 28, 1194, 10.1111/jgh.12134 · DOI
  34. Leung, 2011, Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: A case-control study, J. Epidemiol. Community Health, 65, 556, 10.1136/jech.2009.104125 · DOI
  35. Jang, 2013, The effect of coffee consumption on the development of hepatocellular carcinoma in hepatitis B virus endemic area, Liver Int., 33, 1092, 10.1111/liv.12186 · DOI
  36. Ong, 2011, The effect of caffeine and alcohol consumption on liver fibrosis—A study of 1045 Asian hepatitis B patients using transient elastography, Liver Int., 31, 1047, 10.1111/j.1478-3231.2011.02555.x · DOI
  37. Park, 2012, Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation, J. Clin. Gastroenterol., 46, 602, 10.1097/MCG.0b013e3182582a31 · DOI
  38. Chan, 2009, Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B, J. Viral Hepat., 16, 36, 10.1111/j.1365-2893.2008.01037.x · DOI
  39. Tapper, 2012, Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection, Clin. Gastroenterol. Hepatol., 10, 932.e1, 10.1016/j.cgh.2012.01.015 · DOI
  40. Saab, 2014, Impact of coffee on liver diseases: A systematic review, Liver Int., 34, 495, 10.1111/liv.12304 · DOI
  41. Vitaglione, 2010, Coffee reduces liver damage in a rat model of steatohepatitis: The underlying mechanisms and the role of polyphenols and melanoidins, Hepatology, 52, 1652, 10.1002/hep.23902 · DOI
  42. Moreno, 2011, Coffee prevents CCl(4)-induced liver cirrhosis in the rat, Hepatol. Int., 5, 857, 10.1007/s12072-010-9247-6 · DOI
  43. Arauz, 2013, Coffee attenuates fibrosis by decreasing the expression of TGF-β and CTGF in a murine model of liver damage, J. Appl. Toxicol., 33, 970, 10.1002/jat.2788 · DOI
  44. Shi, 2010, Protective effect of a coffee preparation (Nescafe pure) against carbon tetrachloride-induced liver fibrosis in rats, Clin. Nutr., 29, 399, 10.1016/j.clnu.2009.12.007 · DOI
  45. Shin, 2010, Experimental evidence for the protective effects of coffee against liver fibrosis in SD rats, J. Sci. Food Agric., 90, 450, 10.1002/jsfa.3838 · DOI
  46. Salomone, 2014, Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease, Transl. Res., 163, 593, 10.1016/j.trsl.2013.12.001 · DOI
  47. Shim, 2013, Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model, J. Gastroenterol. Hepatol., 28, 1877, 10.1111/jgh.12317 · DOI
  48. Gressner, 2009, Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells, Liver Int., 29, 886, 10.1111/j.1478-3231.2009.01987.x · DOI
  49. Wan, 2013, Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α in hypercholesterolemic rats induced with a high-cholesterol diet, Phytother. Res., 27, 545, 10.1002/ptr.4751 · DOI

Cited by

Metadata

Authors
Hodge, A., Lim, S., Goh, E., Wong, O., Marsh, P., Knight, V., Sievert, W., & De Courten, B.
Venue
Nutrients
Publisher
MDPI AG
Published
2017-01-10
Volume
9
Issue
1
Pages
56
ISSN
2072-6643
DOI
10.3390/nu9010056
Cited by
42
References
3
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.